Novavax COVID-19 vaccine as a second dose generates high immune response in young people, finds study

Novavax COVID-19 vaccine as a second dose generates high immune response in young people

  • Reactions were mostly mild-to-moderate, with fewest reactions in the fractional Pfizer-BioNTech group
  • Participants in the fractional Pfizer-BioNTech group were more likely to have a breakthrough infection than the standard Pfizer-BioNTech and Novavax groups Antibody responses were similar for all three groups at 236 days after second doses were administered

Source: Read Full Article

Related posts:
  1. You don’t have to go cold turkey on red meat to see health benefits
  2. Assessing state of the art in AI for brain disease treatment
  3. Celebrate Autumn Traditions Without Raising Your COVID Risk
  4. Mastercard, b.well launch tech to enable patient ID verification
  5. What Is The TikTok Milk Crate Challenge? Experts Say This Viral Trend Could Cause Serious Injuries